课题基金 / 基金详情

The study of roles of Rho family GTPase in progression and metastasis of renal cell cancer

The study of roles of Rho family GTPase in progression and metastasis of renal cell cancer
Rho家族GTPase在肾细胞癌进展和转移中的作用研究
批准号:
14571517
负责人:
KAMAI Takao
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We analyzed the mRNA levels of RhoA, RhoB, RhoC and ROCK gene in the surgical specimens of RCC tissues from 78 consecutive Japanese patients and in the corresponding non-tumor tissue originating from the same patient using polymerase chain reaction after reverse transcription (RT-PCR). We compared their expression levels in tumor tissues with those in non-tumor tissues and evaluated the relationship between their expression levels in tumors and clinicopathological features.The mRNA levels of RhoC and ROCK were increased in tumor tissues, compared with those in non-tumor tissues of the resected testis (P<0.0001, P<0.0001, respectively). There was no difference between the expression levels of mRNAs for RhoA. Although RhoB mRNA levels were higher in tumor tissues than those in non-tumor tissues (P<0.05), its expression was not associated with tumor grade, stage and prognosis. The increase of the RhoC and ROCK mRNA levels was related to the tumor grade (P<0.05, P<0.05, respectively) and s … More tage (P<0.0001, P<0.0001, respectively). There was a positive relationship between expression levels of mRNAs of RhoC and ROCK in tumor tissues (P<0.0001). Kaplan-Meier plots of survival rate in patients with low versus high mRNA levels of RhoC and ROCK showed that high mRNA levels of RhoC and ROCK were associated with overall survival (P<0.0001, P<0.0001, respectively). Multivariate analysis showed that mRNA levels of RhoC and ROCK were independent prognostic factors in overall survival.In renal pelvis and ureter cancer, the higher expression of RhoA and ROCK proteins were associated poorly differentiated grade, higher stage, and unfavorable prognosis 1).In bladder cancer, although the higher protein levels of RhoA, RhoC, and ROCK were related to poorly differentiated grade, higher stage, and unfavorable prognosis, the lower RhoB levels were shown in advanced tumors 2).In testicular germ cell tumor, the higher expressions of RhoA, ROCK, Rac1 and Cdc42 were associated with advanced stage of the disease 3). Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Takao Kamai, Satoru Kawakami, Fumitaka Koga, Gaku Arai, Kentaro Takagi, Kyoko Arai, Toshihiko Tsujii, Ken-ichiro Yoshida: "RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer."BJU Int.. 89. 449-453 (2003)
Takao Kamai、Satoru Kawakami、Fumitaka Koga、Gaku Arai、Kentaro Takagi、Kyoko Arai、Toshihiko Tsujii、Ken-ichiro Yoshida:“RhoA 与上尿路癌的侵袭和淋巴结转移有关。”BJU Int.. 89. 449
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takao Kamai: "Significant association of Rho/ROCK Pathway with invasion and metastasis of bladder cancer."Clin.Cancer Res.. 9(7). 2632-2641 (2003)
Takao Kamai:“Rho/ROCK 通路与膀胱癌侵袭和转移的显着关联。”Clin.Cancer Res.. 9(7)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takao Kamai: "The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour"BJU International. 89. 449-458 (2002)
Takao Kamai:“rho/rho-激酶途径参与睾丸生殖细胞肿瘤的进展”BJU International。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takao Kamai, Tomonori Yamanishi, Hiromichi Shirataki, Kentaro Takagi, Hidekazu Asami, Yuji Ito, Ken-Ichiro Yoshida.: "Overexpression of RhA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer."Clin Cancer Res.. (acceptance). (2004
Takao Kamai、Tomonori Yamanishi、Hiromichi Shirataki、Kentaro Takagi、Hidekazu Asami、Yuji Ito、Ken-Ichiro Yoshida.:“RhA、Rac1 和 Cdc42 GTP 酶的过度表达与睾丸癌的进展相关。”Clin Cancer Res..(接受
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    国内基金
    海外基金
    Rho-GTPase 通过调控TNTs 组装保障TC-cTECs间线粒体转移促进产后胸腺再生的机制研究
    • 批准号:
      ZCLQN26H0401
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      许勰
    • 依托单位:
    角质形成细胞中特异性缺失FDPS通过FPP-GTPase-Bcl2通路促进自身免疫反应的作用及机制研究
    • 批准号:
      2025JJ30036
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吴海竞
    • 依托单位:
    Rab GTPase在迁移体发生中的机制和功能研究
    • 批准号:
      32300570
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      陈扬
    • 依托单位:
    拟南芥Rab GTPase协同调控PRKs和ALA3精细定位的机理研究
    • 批准号:
      32300303
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2023
    • 负责人:
      杨洋
    • 依托单位: